![](/img/cover-not-exists.png)
262 Secukinumab demonstrates rapid and sustained efficacy in ankylosing spondylitis patients with normal or elevated baseline C-reactive protein levels: pooled analysis of two Phase 3 studies
Barkham, Nick, Braun, Jürgen, Sieper, Joachim, Landewé, Robert, Baraliakos, Xenofon, Miceli-Richard, Corinne, Quebe-Fehling, Erhard, Porter, Brian, Gandhi, Kunal, van der Heijde, DésiréeVolume:
58
Language:
english
Journal:
Rheumatology
DOI:
10.1093/rheumatology/kez107.078
Date:
April, 2019
File:
PDF, 80 KB
english, 2019